Clinical Trial Update: DEgenerative ROtator Cuff Disease and Botulinum TOXin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating botulinum toxin for degenerative rotator cuff disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Rotator Cuff Disease

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Degenerative Rotator Cuff Disease | Phase 2 | Status: RECRUITING